Keith Lamont Cummings - 22 Dec 2022 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Chief Financial Officer
Signature: /s/ Mike Ouimette, attorney-in-fact
Issuer symbol: PLRX
Transactions as of: 22 Dec 2022
Net transactions value: +$8,320
Form type: 4
Filing time: 27 Dec 2022, 15:30:26 UTC
Previous filing: 21 Dec 2022
Next filing: 25 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLRX	Common Stock	Options Exercise	$8,320	+4,000	+5%	$2.08^*	84,424	22 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (right to buy)	Options Exercise	$0	-4,000	-2.7%	$0.000000	146,097	22 Dec 2022	Common Stock	4,000	$2.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.